TNF and infection: ,23 Prior infection was independently associated with higher vaccine-induced neutralising antibody responses, even after a third dose of vaccine, consistent with the likelihood that further vaccine boosters will continue to incrementally increase neutralising antibody responses, which may be especially important in patients treated with anti-TNF drugs or tofacitinib, who have lower circulating antibody levels, particularly against emerging VOCs.